Shire Financial Results | Takeda Pharmaceuticals
Shire Financial Results
2018
Q3
Q2
Q1
Other presentations
2017
### Q4
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364170/Global/Investor/Legacy-Shire/2017/FY2017_Q4_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364168/Global/Investor/Legacy-Shire/2017/FY2017_Q4_Press_Release.pdf)
### Q3
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364163/Global/Investor/Legacy-Shire/2017/FY2017_Q3_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364161/Global/Investor/Legacy-Shire/2017/FY2017_Q3_Press_Release.pdf)
### Q2
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364160/Global/Investor/Legacy-Shire/2017/FY2017_Q2_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364163/Global/Investor/Legacy-Shire/2017/FY2017_Q2_Press_Release.pdf)
### Q1
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364158/Global/Investor/Legacy-Shire/2017/FY2017_Q1_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364157/Global/Investor/Legacy-Shire/2017/FY2017_Q1_Press_Release.pdf)
2016
### Q4
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364155/Global/Investor/Legacy-Shire/2016/FY2016_Q4_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364155/Global/Investor/Legacy-Shire/2016/FY2016_Q4_Press_Release.pdf)
### Q3
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364154/Global/Investor/Legacy-Shire/2016/FY2016_Q3_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364156/Global/Investor/Legacy-Shire/2016/FY2016_Q3_Press_Release.pdf)
### Q2
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364155/Global/Investor/Legacy-Shire/2016/FY2016_Q2_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364156/Global/Investor/Legacy-Shire/2016/FY2016_Q2_Press_Release.pdf)
### Q1
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364154/Global/Investor/Legacy-Shire/2016/FY2016_Q1_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364151/Global/Investor/Legacy-Shire/2016/FY2016_Q1_Press_Release.pdf)
### Other presentations
* [Creating a Global Biotechnology Company and Leader in Rare Diseases](https://assets-dam.takeda.com/image/upload/v1687364164/Global/Investor/Legacy-Shire/2016/Shire_to_Combine_with_Baxalta_presentation_January_11_2016.pdf)
* [Shire 2016 Investor Day](https://assets-dam.takeda.com/image/upload/v1687364161/Global/Investor/Legacy-Shire/2016/Shire_2016_Investor_Day_presentation_November_10_2016.pdf)
2015
### Q4
* [Presentation ](https://assets-dam.takeda.com/image/upload/v1687364147/Global/Investor/Legacy-Shire/2015/FY2015_Q4_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364150/Global/Investor/Legacy-Shire/2015/FY2015_Q4_Press_Release.pdf)
### Q3
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364146/Global/Investor/Legacy-Shire/2015/FY2015_Q3_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364149/Global/Investor/Legacy-Shire/2015/FY2015_Q3_Press_Release.pdf)
### Q2
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364146/Global/Investor/Legacy-Shire/2015/FY2015_Q2_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364142/Global/Investor/Legacy-Shire/2015/FY2015_Q2_Press_Release.pdf)
### Q1
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364146/Global/Investor/Legacy-Shire/2015/FY2015_Q1_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364141/Global/Investor/Legacy-Shire/2015/FY2015_Q1_Press_Release.pdf)
### Other presentations
* [20 x 20: Creating the Global Leader in Rare Diseases](https://assets-dam.takeda.com/image/upload/v1687364151/Global/Investor/Legacy-Shire/2015/Proposed_Combination_with_Baxalta_presentation_August_4_2015.pdf)
* [Shire to acquire NPS Pharmaceuticals](https://assets-dam.takeda.com/image/upload/v1687364149/Global/Investor/Legacy-Shire/2015/Shire_to_Acquire_NPS_Pharmaceuticals_presentation_January_11_2015.pdf)
* [Shire to acquire Dyax Corp. ](https://assets-dam.takeda.com/image/upload/v1687364147/Global/Investor/Legacy-Shire/2015/Shire_to_Acquire_Dyax_Corp_presentation_November_2_2015.pdf)
2014
### Q4
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364143/Global/Investor/Legacy-Shire/2014/FY2014_Q4_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364142/Global/Investor/Legacy-Shire/2014/FY2014_Q4_Press_Release.pdf)
### Q3
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364140/Global/Investor/Legacy-Shire/2014/FY2014_Q3_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364142/Global/Investor/Legacy-Shire/2014/FY2014_Q3_Press_Release.pdf)
### Q2
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364139/Global/Investor/Legacy-Shire/2014/FY2014_Q2_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364138/Global/Investor/Legacy-Shire/2014/FY2014_Q2_Press_Release.pdf)
### Q1
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364137/Global/Investor/Legacy-Shire/2014/FY2014_Q1_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364137/Global/Investor/Legacy-Shire/2014/FY2014_Q1_Press_Release.pdf)
### Other presentations
* [Shire R&D Day](https://assets-dam.takeda.com/image/upload/v1687364151/Global/Investor/Legacy-Shire/2014/Shire_R_D_Day_presentation_December_10_2014.pdf)
2013
### Q4
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364137/Global/Investor/Legacy-Shire/2013/FY2013_Q4_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364138/Global/Investor/Legacy-Shire/2013/FY2013_Q4_Press_Release.pdf)
### Q3
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364136/Global/Investor/Legacy-Shire/2013/FY2013_Q3_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364136/Global/Investor/Legacy-Shire/2013/FY2013_Q3_Press_Release.pdf)
### Q2
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364135/Global/Investor/Legacy-Shire/2013/FY2013_Q2_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364134/Global/Investor/Legacy-Shire/2013/FY2013_Q2_Press_Release.pdf)
### Q1
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364133/Global/Investor/Legacy-Shire/2013/FY2013_Q1_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364133/Global/Investor/Legacy-Shire/2013/FY2013_Q1_Press_Release.pdf)
### Other presentations
* [Shire acquisition of ViroPharma](https://assets-dam.takeda.com/image/upload/v1687364131/Global/Investor/Legacy-Shire/2013/Acquisition_of_Viro_Pharma_presentation_November_11_2013.pdf)
2012
### Q4
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364129/Global/Investor/Legacy-Shire/2012/FY2012_Q4_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364128/Global/Investor/Legacy-Shire/2012/FY2012_Q4_Press_Release.pdf)
### Q3
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364129/Global/Investor/Legacy-Shire/2012/FY2012_Q3_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364130/Global/Investor/Legacy-Shire/2012/FY2012_Q3_Press_Release.pdf)
### Q2
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364129/Global/Investor/Legacy-Shire/2012/FY2012_Q2_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364123/Global/Investor/Legacy-Shire/2012/FY2012_Q2_Press_Release.pdf)
### Q1
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364133/Global/Investor/Legacy-Shire/2012/FY2012_Q1_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364115/Global/Investor/Legacy-Shire/2012/FY2012_Q1_Press_Release.pdf)
2011
### Q4
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364122/Global/Investor/Legacy-Shire/2011/FY2011_Q4_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364123/Global/Investor/Legacy-Shire/2011/FY2011_Q4_Press_Release.pdf)
### Q3
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364129/Global/Investor/Legacy-Shire/2011/FY2011_Q3_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364120/Global/Investor/Legacy-Shire/2011/FY2011_Q3_Press_Release.pdf)
### Q2
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364121/Global/Investor/Legacy-Shire/2011/FY2011_Q2_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364119/Global/Investor/Legacy-Shire/2011/FY2011_Q2_Press_Release.pdf)
### Q1
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364121/Global/Investor/Legacy-Shire/2011/FY2011_Q1_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364114/Global/Investor/Legacy-Shire/2011/FY2011_Q1_Press_Release.pdf)
2010
### Q4
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364134/Global/Investor/Legacy-Shire/2010/FY2010_Q4_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364117/Global/Investor/Legacy-Shire/2010/FY2010_Q4_Press_Release.pdf)
### Q3
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364121/Global/Investor/Legacy-Shire/2010/FY2010_Q3_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364119/Global/Investor/Legacy-Shire/2010/FY2010_Q3_Press_Release.pdf)
### Q2
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364116/Global/Investor/Legacy-Shire/2010/FY2010_Q2_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364118/Global/Investor/Legacy-Shire/2010/FY2010_Q2_Press_Release.pdf)
### Q1
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364114/Global/Investor/Legacy-Shire/2010/FY2010_Q1_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364115/Global/Investor/Legacy-Shire/2010/FY2010_Q1_Press_Release.pdf)
2009
### Q4
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364131/Global/Investor/Legacy-Shire/2009/FY2009_Q4_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364120/Global/Investor/Legacy-Shire/2009/FY2009_Q4_Press_Release.pdf)
### Q3
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364113/Global/Investor/Legacy-Shire/2009/FY2009_Q3_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364117/Global/Investor/Legacy-Shire/2009/FY2009_Q3_Press_Release.pdf)
### Q2
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364114/Global/Investor/Legacy-Shire/2009/FY2009_Q2_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364113/Global/Investor/Legacy-Shire/2009/FY2009_Q2_Press_Release.pdf)
### Q1
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364112/Global/Investor/Legacy-Shire/2009/FY2009_Q1_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364114/Global/Investor/Legacy-Shire/2009/FY2009_Q1_Press_Release.pdf)
2008
### Q4
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364082/Global/Investor/Legacy-Shire/2008/FY2008_Q4_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364082/Global/Investor/Legacy-Shire/2008/FY2008_Q4_Press_Release.pdf)
### Q3
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364079/Global/Investor/Legacy-Shire/2008/FY2008_Q3_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364080/Global/Investor/Legacy-Shire/2008/FY2008_Q3_Press_Release.pdf)
### Q2
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364079/Global/Investor/Legacy-Shire/2008/FY2008_Q2_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364079/Global/Investor/Legacy-Shire/2008/FY2008_Q2_Press_Release.pdf)
### Q1
* [Presentation](https://assets-dam.takeda.com/image/upload/v1687364080/Global/Investor/Legacy-Shire/2008/FY2008_Q1_Presentation.pdf)
* [Press Release](https://assets-dam.takeda.com/image/upload/v1687364080/Global/Investor/Legacy-Shire/2008/FY2008_Q1_Press_Release.pdf)